By 2030, the EMEA Blood Glucose Monitoring Market Trends Uncovers Industry Revenue worth USD 13,721 Million

Comments · 390 Views

EMEA blood glucose monitoring market is expected to reach USD 13,721 Million by 2030 at a CAGR of 10.5% during the forecast period 2022-2030

EMEA Blood Glucose Monitoring Market Highlights

EMEA blood glucose monitoring market share report expects the industry to reach USD 13,721 Million by 2030 at a CAGR of 10.5% during the forecast period 2022-2030.

The EMEA Blood Glucose Monitoring Market is one of the rapidly growing markets owing to huge growth in urbanization leading to the increased incidence of obesity, unhealthy diet, and physical inactiveness, which has increased the diabetic population around the globe. Regular monitoring of glucose level is important to avoid further complications. Furthermore, invention of new technology, increasing awareness, investment in research and development have boosted the market globally. However, high cost associated with monitoring and diagnosis of disease may restrain the market growth.

Regional Analysis

On the regional basis, Europe, Middle East, and Africa blood glucose monitoring market is segmented into two major regions Europe and the Middle East and Africa.

Segmentation

EMEA Blood Glucose Monitoring Market is segmented on the basis of product type, application, and end user.

On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.

On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.

On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.

Key Players

Some of the key players mentioned in the EMEA Blood Glucose Monitoring Market trends report are Abbott Laboratories (US), Arkay Inc. (Japan), Bayer Healthcare AG, (Germany), F.Hoffmann-La Roche (Switzerland), LifeScan, Johnson & Johnson (U.S.), Medtronic plc., Nipro Diagnostics Inc., and Terumo Medical Corporation.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com

Comments